Document is current

Article History

Accepted: 14 August 2023

First Online: 14 September 2023

Declarations

:

: This study was conceptualized by AJH, MAC, JWS, JRP and RL; the analyses were performed by KF, AMK and RL; interpretation was provided by AJH, MAC, GM, AMK, JWS, JRP and RL; and the manuscript was drafted by AJH and RL. All authors read and approved the final version.

: Anthony J. Hatswell is an employee of Delta Hat, who were funded by BMS (the owners of the trial data) for their involvement in this study. Mohammad A. Chaudhary, James W. Shaw, and John R. Penrod are employees of BMS. Giles Monnickendam is an employee of Ceelos Consulting and a member of the NICE Technology Appraisal Committee. Alejandro Moreno-Koehler, Katie Frampton, and Rachael Lawrance are employees of Adelphi Values, who were funded by BMS for involvement in the study.

: This study was funded by BMS.

: This study used data from BMS clinical trials. BMS operate a data sharing request process whereby trial data can be requested, details can be found at .

: Not applicable.

: Not applicable.

: Not applicable.

: Analyses were performed using SAS and R, and are designed to be reproducible using the methodology described in the article.